News
Oncoinvent ASA: Grant of share options – mandatory notification of trade
Oncoinvent ASA: New share capital registered
Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology
Oncoinvent ASA: Notification of trade – primary insider/close associate
Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee
Oncoinvent ASA: Minutes from Extraordinary General Meeting
Oncoinvent ASA: Notification of trade – primary insider/close associate
Oncoinvent ASA: Final results of the rights issue
Oncoinvent ASA: Preliminary results of the rights issue
